“Risk-Based Vendor Oversight: Governance in Global Pharmacovigilance”, Int Res J Adv Engg Hub, vol. 4, no. 07, pp. 5100–5108, Aug. 2026, doi: 10.47392/IRJAEH.2026.0670.